Login / Signup
Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits.
Gerasimos Siasos
Evaggelos Oikonomou
Dimitris Tousoulis
Published in:
European heart journal. Cardiovascular pharmacotherapy (2022)
Keyphrases
</>
low density lipoprotein